Skip to main content

Table 3 Effect of SAA on bacterial mutation assay

From: Non-clinical safety evaluation of salvianolic acid A: acute, 4-week intravenous toxicities and genotoxicity evaluations

Test Article

Dose (µg/plate)

S9 mix

Number of revertant colonies

TA97

TA98

TA100

TA1535

TA102

Vehicle control

 

-

145.0 ± 2.0

38.7 ± 4.5

151.7 ± 9.9

19.0 ± 7.5

252.0 ± 23.5

+

128.0 ± 6.0

40.0 ± 20.7

141.0 ± 25.1

16.0 ± 6.9

287.0 ± 22.1

Positive control

 

-

1508.0 ± 10.6

247.7 ± 25.5

3821.3 ± 398.5

2288.0 ± 246.6

986.7 ± 282.3

 

+

1228.0 ± 25.0

404.0 ± 43.3

2612.0 ± 255.9

1729.3 ± 93.6

1218.3 ± 149.1

SAA

5000

-

125.3 ± 20.6

28.3 ± 2.1

159.0 ± 14.9

16.7 ± 4.5

246.0 ± 17.6

 

+

146.3 ± 3.1

42.0 ± 13.9

155.0 ± 11.1

14.3 ± 2.9

304.7 ± 17.4

1000

-

143.0 ± 6.0

31.7 ± 4.9

162.3 ± 23.2

15.3 ± 4.9

251.3 ± 20.6

 

+

152.0 ± 18.0

38.7 ± 6.7

161.0 ± 4.4

18.7 ± 0.6

298.0 ± 24.0

100

-

136.7 ± 8.5

35.0 ± 7.8

160.7 ± 11.0

11.7 ± 2.5

250.7 ± 13.2

 

+

125.0 ± 33.1

45.0 ± 16.8

148.0 ± 2.6

14.7 ± 4.2

295.0 ± 21.7

10

-

135.3 ± 10.4

34.7 ± 4.0

168.3 ± 6.4

12.3 ± 4.0

238.3 ± 6.7

 

+

140.0 ± 9.0

43.0 ± 15.6

142.7 ± 3.8

16.3 ± 3.8

298.7 ± 27.4

1

-

137.7 ± 8.5

40.0 ± 2.6

153.3 ± 2.1

17.7 ± 1.5

254.0 ± 5.2

 

+

139.0 ± 10.6

46.3 ± 11.7

129.0 ± 21.0

16.7 ± 4.5

287.7 ± 13.6

9-aminoacridine 50 µg/plate 2,7-diaminofluorene 20 µg/plate Sodium azide 1.5 µg/plate

Mitomycin C 0.5 µg/plate 2-aminofluorene 50 µg/plate 1,8-dihydroxyanthraquinone 50 µg/plate